Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1631 1632 1635 1699
This examiner grants 61% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18026474 | CELL SUPPORT AND METHOD OF PRODUCING SAME, CELL CULTURE METHOD AND CELL STRUCTURE | Final Rejection | Konica Minolta, Inc. |
| 18416749 | METHODS FOR SCREENING GENETIC PERTURBATIONS | Final Rejection | The Regents of the University of California |
| 17549028 | PHYSIOLOGIC GROWTH OF CULTURED INTESTINAL TISSUE | Final Rejection | The Regents of the University of Michigan |
| 18696014 | TREATMENT OF POLYCYTHEMIA VERA VIA CRISPR/AAV6 GENOME EDITING | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 17168988 | ARRDC1-MEDIATED MICROVESICLES (ARMMS) AND USES THEREOF | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 19353269 | SELECTIVE TARGETING OF HOST CD70+ ALLOREACTIVE CELLS TO PROLONG ALLOGENEIC CAR T CELL PERSISTENCE | Non-Final OA | Allogene Therapeutics, Inc. |
| 17841041 | SELECTIVE TARGETING OF HOST CD70+ ALLOREACTIVE CELLS TO PROLONG ALLOGENEIC CAR T CELL PERSISTENCE | Final Rejection | Allogene Therapeutics, Inc. |
| 16968941 | DECELLULARIZED TISSUES, HYDROGELS THEREOF, AND USES THEREOF | Final Rejection | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION |
| 18035277 | CELLS EXPRESSING A CHIMERIC RECEPTOR FROM A MODIFIED INVARIANT CD3 IMMUNOGLOBULIN SUPERFAMILY CHAIN LOCUS AND RELATED POLYNUCLEOTIDES AND METHODS | Non-Final OA | Juno Therapeutics, Inc. |
| 18941862 | BIOACTIVE AND ANTIOXIDANT SUPRAMOLECULAR POLYMER HYDROGELS FOR NEURAL CELL CULTURE | Non-Final OA | Northwestern University |
| 18929526 | COST EFFECTIVE CULTURE MEDIA AND PROTOCOL FOR HUMAN INDUCED PLURIPOTENT STEM CELLS | Non-Final OA | Northwestern University |
| 17757503 | T-CELL DEATH ASSOCIATED GENE 8 (TDAG8) MODULATION TO ENHANCE CELLULAR CANCER THERAPIES | Non-Final OA | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM |
| 16960445 | 3D in vitro Models of Lung Tissue | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE |
| 17770585 | ENGINEERED NATURAL KILLER CELLS AND METHODS FOR USING THE SAME IN IMMUNOTHERAPY AND AUTOPHAGY INHIBITON TECHNIQUES | Final Rejection | Purdue Research Foundation |
| 17669904 | DIAGNOSIS AND TREATMENT OF CARDIOMYOPATHY | Non-Final OA | The General Hospital Corporation |
| 17786255 | CHIMERIC ANTIGEN RECEPTOR DENDRITIC CELLS (CAR-DCS) AND METHODS OF MAKING AND USING SAME | Final Rejection | Washington University |
| 17495597 | MULTICELL CONJUGATES FOR ACTIVATING ANTIGEN-SPECIFIC T CELL RESPONSES | Final Rejection | Wisconsin Alumni Research Foundation |
| 17778611 | T-CELL MASTER CELL BANK | Non-Final OA | Takeda Pharmaceutical Company Limited |
| 18036909 | MICROFLUIDIC-BASED BLADDER CANCER MIMIC AND USE THEREOF | Final Rejection | CHUNG ANG UNIVERSITY INDUSTRY ACADEMIC COOPERATION FOUNDATION |
| 18807699 | SYSTEMS, DEVICES, AND METHODS FOR CONDITIONAL EXECUTION OF AUTOMATIC CELL PROCESSING | Non-Final OA | Cellares Corporation |
| 17773103 | METHOD FOR THE PRODUCTION OF MÜLLER CELLS AND CELL PRODUCT | Non-Final OA | UCL BUSINESS LTD |
| 16968315 | BIOPROCESSING METHODS FOR CELL THERAPY | Final Rejection | Global Life Sciences Solutions USA LLC |
| 17258820 | MYOCARDIAL ORGANOIDS AND METHODS OF MAKING AND USES THEREOF | Non-Final OA | CLEMSON UNIVERSITY RESEARCH FOUNDATION |
| 17908857 | UP-SCALED PRODUCTION OF MICROGLIA-LIKE/-PRECURSOR CELLS AND MACROPHAGE CELLS USING MESH MACROCARRIERS | Non-Final OA | RHEINISCHE FRIEDRICH-WILHELMS-UNIVERSITÄT BONN |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy